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Poor inhaler technique is frequent in asthma, but its long-term consequences have been
seldom assessed. Pharmacists are ideally positioned to teach inhaler technique.
This prospective observational study evaluated the feasibility of inhaler training by pharma-
cists in patients receiving inhaled corticosteroids by pressurised metered-dose inhaler (pMDI)
or breath-actuated MDI. In parallel, the relationships between inhaler technique, adherence,
and asthma control, and their modulation one month after training were assessed.
Of 727 patients receiving training at pharmacies (nZ 123), 61% were prescribed a pMDI; 35%,
an Autohaler; and 5%, an Easi-Breathe inhaler. Poor asthma control (Asthma Control Ques-
tionnaire score 1.5) at baseline was significantly (p< 0.05) and independently associated
with poor inhaler technique and poor self-reported adherence (Morisky score 3). The
percentage of patients with optimal inhaler technique rose from 24% before to 79% after
training (p< 0.001). Median training session length was 6 min. At 1 month, mean (SD) ACQ
score had improved from a baseline score of 1.8 (1.2) to 1.4 (1.1), (p< 0.001). Importantly,
greater change was observed in patients with improved inhaler technique versus those
without. Similar results were observed for Morisky score.
Inhaler technique is associated with adherence and influences asthma control. Inhaler
training by pharmacists is feasible and seams to improve inhaler technique, asthma control
and adherence.
ª 2011 Elsevier Ltd. All rights reserved.neumologie, Hoˆpital Ambroise Pare´, 9, avenue Charles de Gaulle, 92104 Boulogne, France. Tel.: þ33
06.
r.aphp.fr (V. Giraud).
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Bronchodilators and most asthma controller therapies such
as inhaled corticosteroids (ICS) are delivered by inhalation.
The inhaled route provides the advantage of direct delivery
to the target organ, thus ideally maximising the desired
effects and minimising potential adverse effects associated
with systemic administration. These benefits, however, are
accompanied by the drawbacks of inhaled therapy, in
particular the challenges patients face in using their inhaler
devices.1 Frequent misuse of inhaler devices has been
documented for patients prescribed metered-dose inhalers
(MDIs) as well as those using dry powder inhalers (DPIs).2e5
Indeed, despite the availability of efficacious therapies,
asthma control is often poor,6,7 and improper use of inhaler
devices is one of the many causes of poor control.1,5,8,9
Asthma management guidelines recommend that patients
be taught proper inhaler handling and technique and that
inhaler technique be checked at each visit.10,11 However,
the provision of inhaler technique training remains irreg-
ular. This is acknowledged by physicians3,12 and corrobo-
rated in a recent patient survey.13
A simple verbal description of how to use an inhaler is
not sufficient to guide patients on correct use of their
inhalers, even the breath-actuated devices.14 Instead,
guidelines recommend that health-care providers demon-
strate proper use as well as ask patients to demonstrate
their inhaler technique.11 Pharmacists are ideally posi-
tioned to teach inhaler technique as they are the last
health-care providers to see patients before asthma medi-
cation is dispensed and are often in frequent patient
contact.
The objectives of this study were to analyse, for patients
with asthma receiving maintenance therapy with ICS
administered through standard pressurised MDIs (pMDIs) or
breath-actuated MDIs (BAIs):
(i) The feasibility and acceptability of education on
inhaler technique in community pharmacies
(ii) Whether there is a link between inhaler technique,
asthma control, and self-reported adherence. The
short-term effects of education by pharmacists on
inhaler technique, asthma control, and adherence to
treatment were assessed. Changes in asthma control
and adherence were compared between patients with
versus without improved inhaler technique.Methods
This prospective observational study was conducted from
September to December 2008 in partnership with a group of
pharmacies, PHR, throughout France. The study medical
team provided a 2-hour training session at each pharmacy
to teach basic asthma treatment principles, correct use of
each of the studied inhaler devices, use of the study check-
lists to evaluate inhaler technique, and development of
individualised instructions for each patient.
Participating pharmacies were asked to enrol the first 10
adult patients (18 years of age) with asthma who received
a prescription for ICS delivered by pMDI or one of two typesof BAI, the Autohaler inhaler device (Teva Sante´, Paris,
France) or the Easi-Breathe inhaler (Teva Sante´, Paris,
France).
Patients completed a questionnaire regarding prior
inhaler training, asthma control, and self-reported adher-
ence to prescribed medication. To assess prior inhaler
training, patients were asked if they had been shown how
to use their inhaler and if they had demonstrated their
inhaler technique for a health-care professional. Asthma
control was quantified using a shortened version of the
Asthma Control Questionnaire (ACQ) without lung function
testing (the ACQ6).15,16 The ACQ6 score is the mean
response to 6 questions (scored from 0, total control, to 6,
severe lack of control), and the cut-point for poor asthma
control is 1.5.17 Self-reported adherence was quantified by
the four-item questionnaire developed by Morisky et al.,18
scored from 0, very good adherence, to 4, very poor
adherence.
Pharmacists evaluated patients’ inhaler technique, using
specific check-lists for each study inhaler device type, both
before and after providing training in inhaler use. For each
patient, they recorded the number of attempts at using the
inhaler and the length of education time required before
obtaining adequate inhaler technique. At the end of the
training session, the pharmacist completed written
instructions for the patient, personalised according to
observed inhaler technique and the errors that had been
identified. The instructions were provided as a self-stick
form that could be attached to the inhaler device.
In addition, patients were given a second questionnaire,
with instructions for completion 1 month later, regarding
their opinion as to the usefulness of training and the per-
sonalised instructions for inhaler use; asthma control and
self-reported adherence were also reassessed. Patients
were provided with a stamped, pre-addressed envelope for
the return of the 1-month questionnaire by post.
The study was approved by the National Committee on
Informatics and Liberty.
Assessment of inhaler technique
Pharmacists evaluated inhaler technique using a check-list
adapted for each inhaler device. Optimal technique was
defined as successful execution of each step on the check-
list without errors. For the purpose of the analysis, critical
errors were defined, per Molimard et al.,3 as errors that
could substantially affect dose delivery to the lung. For all
inhaler devices, these included faulty preparation of the
device such that no dose could be delivered; lack of inha-
lation across the inhaler; lack of exhalation before inhala-
tion; too short or too fast inhalation; inhalation via the
nose; and stopping inhalation after releasing the dose. In
addition, for pMDIs, critical errors included actuating the
dose at the end of the inhalation. Pharmacists were not
aware of the distinction between critical and non-critical
errors.
Statistical analyses
Descriptive statistics were used to summarise outcome
variables. Quantitative variables were compared with
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test. In addition, stepwise logistic regression was per-
formed to identify factors independently associated with
asthma control. Finally, changes between inclusion and
follow-up were assessed using the paired t test for contin-
uous variables and McNemar test for categorical variables.
The statistical software used was SAS version 9.2, and
a p-value of <0.05 was used to denote statistical
significance.
Results
Pharmacies and patients
Of 300 pharmacies solicited, 256 participated in the
training program, and 123 enrolled at least one patient. A
total of 727 patients were included and received inhaler
technique training from a pharmacist; of these, 503 (69.2%)
returned the 1-month follow-up questionnaire. There were
no statistically significant differences in age, sex,
prescribed inhaler device, inhaler technique, ACQ score, or
self-reported adherence between patients who did
(nZ 503) versus did not (nZ 224) complete the 1-month
questionnaire (data not shown).
The majority of the 727 patients who received a phar-
macy training session were prescribed a pMDI (61%); one
third, an Autohaler (34.5%); and a minority, an Easi-Breathe
(4.5%). Patient characteristics by prescribed inhaler type
are summarized in Table 1. Overall, the mean (SD) age of
the 727 participating patients was 52 (19) years; 47% were
men; and 58% were smokers or former smokers. The
prescription was for a first inhaled therapy for 13.5% of
patients, a new inhaler device for 21.2%, and renewal of
previous treatment for the remaining patients.
Inhaler technique, previous education, asthma
control, and self-reported adherence to treatment
before training session
Before the pharmacy training session, one quarter of
patients overall (24.1%) demonstrated an optimal tech-
nique, and 30% did not make any critical error. Tables 2 and
3 present the check-list results for each inhaler type before
and after the training session. There were no differences
with regard to inhaler type.Table 1 Demographic and asthma-related characteristics of
community pharmacists.
Characteristic MDI, nZ 443 (60.9%
n
Age (yr), mean (SD) (range) 438 51.8 (18.4) (1
Male sex, n (%) 439 201 (45.8)
Current smoker, n (%) 441 129 (29.3)
Current or ex-smoker, n (%) 368 208 (56.5)
First prescription of inhaled therapy, n (%) 309 42 (13.6)
New inhaler device type, n (%) 305 51 (16.7)Overall, 67% of patients had been shown how to use their
inhaler by a health-care professional, most commonly
a respiratory physician, general practitioner, or pharma-
cist. But only one third (250/715; 35%) had demonstrated
their inhaler technique to a health-care professional, most
commonly a respiratory physician or general practitioner.
Moreover, only 6 of 72 (8.3%) patients receiving their first
inhaler prescription and 17 of 110 (15.5%) receiving a new
type of inhaler had demonstrated their inhaler technique to
a health-care professional.
At the time of the prescription, the mean ACQ (SD) score
was 1.7 (1.2). For 368 patients (50.6%) the score was 1.5,
indicating poor asthma control. Mean (SD) self-reported
adherence to treatment was 1.3 (1.3). Both ACQ and self-
reported adherence were higher (worse) when inhaler
technique was not optimal: with ACQ score of 1.9 (1.2)
versus 1.4 (1.1), (p< 0.001) and Morisky score of 1.4 (1.3)
versus 1.1 (1.2), (p< 0.01), respectively.
Previous education that included demonstration of
inhaler technique by the patient for a health-care profes-
sional was associated with better inhaler technique,
asthma control, and reported adherence than no education
or education limited to demonstration by the health-care
professional (Table 4).
Using an ACQ score threshold of 1.5 or greater to define
poor control,17 logistic regression including age, sex,
smoking status, inhaler device type, adherence, and inhaler
technique identified poorer asthma control in patients with
non-optimal inhaler technique, smokers, and patients with
poor or very poor adherence (Table 5).Feasibility and immediate efficacy of inhaler
technique training at pharmacies
The percentage of patients judged by pharmacists to have
optimal inhaler technique rose from 24% before to 79% after
training (p< 0.001) (Fig. 1). The median duration of the
training sessions was 6 min (range, 1e30 min) and a median
of 2 (range, 1e10) handling attempts were made before an
adequate inhaler technique was obtained. Over half of
patients (444/704; 63%) received their training session in
a room separate from other customers. There were no
significant differences among inhaler device types for
duration of training or number of handling attempts.
The inhaler training was well accepted by patients. Two
thirds of patients (67%) judged the training to be useful or727 patients who received inhaler technique training by
) Autohaler, nZ 251
(34.5%)
Easi-Breathe, nZ 33
(4.5%)
n n
8e94) 245 53.5 (19.1) (18e88) 32 53.3 (19.3) (18e95)
247 120 (48.6) 32 14 (43.8)
248 60 (24.2) 33 6 (18.2)
215 129 (60.0) 31 19 (61.3)
202 28 (13.9) 30 3 (10.0)
199 54 (27.1) 30 8 (26.7)
Table 2 A comparison of study check-list results before and after training by pharmacists in use of a pressurised metered dose
inhaler.
Study check-list Correct technique* (nZ 443)
Before training After training
Procedural steps to be followed
1. Remove/open the capa 418 (94.4) 431 (97.3)
2. Hold inhaler uprighta 383 (86.5) 432 (97.5)
3. Breathe out gentlya 260 (58.7) 420 (94.8)
4. Put mouthpiece in mouth and close lipsa 358 (80.8) 436 (98.4)
5. Breathe in slowly and deeplya 228 (51.5) 419 (94.6)
6. Actuate at beginning of inhalationa 281 (63.4) 402 (90.7)
7. Maintain breath hold for 5 seconds. 232 (52.4) 416 (93.9)
Possible errors to avoid
1. Inhaling through the nosea 400 (90.3) 442 (99.8)
2. Actuating inhaler at end of inhalationa 380 (85.8) 437 (98.6)
3. Taking more than one puff 363 (81.9) 440 (99.3)
4. No inhalationa 373 (84.2) 434 (98.0)
5. Breathing stopped at actuationa 347 (78.3) 440 (99.3)
Optimal technique 113 (25.5) 243 (79.3)
Data are presented as n (%).
*p< 0.001 (McNemar test) for all comparisons between before and after training.
a Critical error.
1818 V. Giraud et al.very useful. The majority rated the session as not incon-
venient (81%) or minimally inconvenient (15%). The
personalized self-stick instruction form was kept by 76% of
the patients but it was judged useless or of little use by 50%
of the patients.Table 3 A comparison of study check-list results before and aft
Breathe inhaler devices.
Correct techn
(nZ 251)
Before trainin
Procedural steps to be followed
1. Remove/open the capa 225 (89.6)
2. Hold inhaler uprighta 207 (82.5)
3. Raise the lever to the vertical positiona 198 (78.9)
4. Breathe out gentlya 147 (58.6)
5. Put mouthpiece in mouth and close lipsa 196 (78.1)
6. Breathe in slowly and deeplya 138 (55.0)
7. Maintain breath hold for 5 s 115 (45.8)
Possible errors to avoid
1. Inhaling through the nosea 226 (90.0)
2. No inhalationa 221 (88.0)
3. Stop breathing at actuationa 193 (76.9)
4. Put lever down before inhalationa 235 (93.6)
5. Push the languette manually 242 (96.4)
Optimal technique 57 (22.7)
Data are presented as n (%).
*p 0.003 (McNemar test) for all comparisons between before and af
**p< 0.05 (McNemar test) for all comparisons between before and af
both).
a Critical error.Asthma control and adherence to treatment 1
month after training
On the 1-month questionnaire, the mean (SD) ACQ score
had improved significantly relative to the starting scoreer training by pharmacists in use of the Autohaler and Easi-
ique for Autohaler* Correct technique for Easi-
Breathe** (nZ 33)
g After training Before training After training
248 (98.8) 30 (90.9) 33 (100)
245 (97.6) 25 (75.8) 32 (97.0)
240 (95.6) e e
244 (97.2) 18 (54.5) 32 (97.0)
251 (100) 26 (78.8) 32 (97.0)
242 (96.4) 16 (48.5) 33 (100)
251 (100) 13 (39.4) 32 (97.0)
250 (99.6) 29 (87.9) 32 (97.0)
250 (99.6) 29 (87.9) 33 (100)
249 (99.2) 23 (69.7) 33 (100)
249 (99.2) e e
251 (100) e e
195 (77.7) 6 (18.2) 29 (87.9)
ter training.
ter training except procedural step #1 and error #1 (pZ 0.08 for
Table 4 Relationship between previous education and inhaler technique, asthma control and adherence to treatment, as
reported before training.
Previous education on inhaler technique
No education Demonstration by HCP; no
demonstration by patient to
HCP
Education including
demonstration by patient to
HCP
Optimal inhaler technique 10.5% (nZ 23/219) 21.9%b (nZ 53/242) 39.0%b,c (nZ 96/246)
Mean (SD) ACQ score16 2.0 (1.1) (nZ 195) 1.7 (1.1)a (nZ 234) 1.6  1.3b,e (nZ 238)
Morisky score18 1.6 (1.4) (nZ 185) 1.4 (1.3)a (nZ 226) 1.1 (1.2)b,d (nZ 236)
HCP, health-care professional.
a p< 0.05 versus no education.
b p< 0.01 versus no education.
c p< 0.01 versus education without demonstration by patient to HCP.
d p< 0.05 versus education without demonstration by patient to HCP.
e NS versus education without demonstration by patient to HCP.
Inhaler technique, asthma control, pharmacy training 1819from 1.8 (1.2) to 1.4 (1.1) (p< 0.001; nZ 437). In addition,
the mean self-reported adherence to treatment improved
significantly from 1.4 (1.3) to 1.1 (1.3) (p< 0.001; nZ 436),
with the percentage of patients reporting moderate to very
good adherence (score of 0 or 1) increasing from 58.0% to
66.2%.
The mean (SD) improvement in ACQ score for patients
whose inhaler technique became optimal after training by
the pharmacist was 0.4 (0.8), significantly greater
(p< 0.01) than the ACQ score improvement for patients
whose technique remained non-optimal (0.2 [0.8]) or
stayed optimal (0.2 [0.9]). Similarly, the improvement in
Morisky score was significantly greater (p< 0.001) for
patients whose inhaler technique became optimal after
training by the pharmacist (0.4 [1.1]) compared with
those whose technique remained non-optimal (0.3 [1.1])
or stayed optimal (0.1 [1.1]).
In the subgroup of patients receiving renewed prescrip-
tions for previous ICS (nZ 414), the improvement in ACQ
score was also significantly greater (p< 0.05) for patients
whose inhaler technique became optimal after training byTable 5 Logistic regression: odds for poor asthma control at bas
1.517 (bimodal test).
Odds ratio
Age 55 years (vs. <55 years
old)
1.20
Female sex (vs. male) 1.05
Inhaler device type
Autohaler (vs pMDI) 0.78
Easi-Breathe (vs pMDI) 0.51
Smoker (vs. non-smoker) 1.53
Adherencea poor or very poor
(vs. moderate or very good)
1.68
Pre-training inhaler technique
non-optimal (vs. optimal)
1.89
pMDI, pressurised metered-dose inhaler.
a Self-reported adherence according to Morisky questionnaire.18the pharmacist (0.4 [0.8]) compared with those whose
technique remained non-optimal (0.1 [0.9]) or stayed
optimal (0.2 [0.9]). However in this subgroup, there was
no difference according to inhaler technique improvement
for change in Morisky score.Discussion
Inhaler training that includes patients demonstrating inhaler
technique for their physicians is not yet conducted in
everyday practice, and only one quarter of patients in this
study showedoptimal inhaler techniquebefore thepharmacy
training session. Patients who showed incorrect inhaler
technique had nearly two times higher odds for poor asthma
control as defined by an ACQ score 1.5. The educational
intervention by pharmacists resulted in improved inhaler
technique at theendof the session and, at 1month, improved
asthma control and self-reported adherence to prescribed
treatment. Our findings suggest that this type of patient
training by pharmacists is feasible in everyday practice.eline (before inhaler technique training) defined as ACQ score
95% CI p-Value
0.86e1.68 0.28
0.76e1.45 0.77
0.56e1.10 0.15
0.24e1.09 0.082
1.05e2.22 0.026
1.21e2.33 0.002
1.31e2.75 0.0008
020
40
60
80
100
120
Before training After training
all steps
no error
optimal technique 
Fig. 1 Results of the inhaler technique training sessions:
percentage of patients who successfully followed all proce-
dural steps and committed no error and therefore had optimal
technique before and after the inhaler technique training
session (nZ 727).
1820 V. Giraud et al.Inhaler training and its relationship with inhaler
technique and asthma outcomes
Demonstration by patients of inhaler technique for a health-
care professional who can then provide individualised
instruction should be considered the minimal necessary
inhaler training. However, in this study, two of three patients
overall, and over 90% with a first inhaler prescription, had
not had this opportunity. The question thus arises: how does
one incorporate this approach, seemingly simple and rapid,
into everyday practice? Training of all health-care providers
is necessary, in addition to making available both placebo
and disposable mouthpieces.
The training provided by pharmacists in the present
study was of relatively short duration and appears to be
compatible with everyday practice. Moreover, the training
method was useful for both pMDIs and the two BAI devices.
Nonetheless, without an objective measure of the inhala-
tion manoeuvre, it is possible that patients’ post-training
inhaler technique was overestimated, particularly that for
pMDIs, which require coordination of actuation and inha-
lation. Indeed, the findings of an English study that used the
Aerosol Inhalation Monitor (AIM, Vitalograph), which
measures inspiratory flow and can confirm coordination of
actuation and inhalation, indicate that more than half of
patients, despite repeated training, are unable to master
correct pMDI technique.19
The association of poor pMDI technique with uncon-
trolled asthma, exacerbations, and need for oral cortico-
steroid therapy has been reported20,21; however, this is the
first study investigating other inhaler devices. For these,the association remains strong after adjustment for other
factors known to be associated with poor asthma control,
including smoking and adherence. Thus, it is crucial to
choose an inhaler device appropriate for each individual
patient.22
Role of pharmacists
Asthma guidelines recommend that inhaler training should
be repeated and that all health-care professionals should
participate.11 Pharmacists are particularly well placed for
this role, as they are the last health-care providers with
patient contact before dispensed asthma medication is
used, and they have more frequent contacts with patients
than doctors. Indeed, the role of pharmacists in providing
patient education about asthma and inhaler technique is
considered to be an important element in the success of the
Finnish program in improving asthma control.23 Thus, the
French Health Authorities are planning to provide all
pharmacies with instruction leaflets for each inhaler type
to encourage pharmacists to educate patients.
Nonetheless, the role of pharmacists in improving
asthma outcomes remains to be formally studied, as prior
programs and outcomes analysed are inconsistent.24
Armour and coworkers25 report the success of a complex
intervention targeted to patients with poor asthma control
by remunerated pharmacists that encompassed patient
education on asthma, elimination of trigger factors, treat-
ment, adherence, inhaler technique training, and referral
to a physician if warranted. Success of the intervention was
measureable in terms of improved asthma control and
adherence with controller therapy. Similarly, a less
complex intervention centred on adherence and inhaler
training was shown to improve inhaler technique and
asthma control for patients with poor control, as evaluated
using the Asthma Control Test.26 Of note, even a simple
intervention of inhaler technique training has been shown
to improve inhaler technique and asthma control.27,28
Study limitations
Pharmacy setting may reduce potential biases that could
result from physicians surveying their own patients.
However, this observational study has several limitations,
including the lack of randomisation and a short period of
observation. Indeed, the short duration of follow-up (1
month) makes it mandatory to confirm the positive impact
of inhaler training on asthma control and adherence over
a longer period of observation.
Nonetheless, results are strengthened by the observa-
tion that ACQ and self-reported adherence improved more
in patients whose inhaler technique improved after
training, suggesting its efficacy. Similarly, in the subgroup
of patients already receiving maintenance treatment
before inclusion in the study, ACQ decreased only in those
with improved inhaler technique.
In this study only patients treated with MDI or breath
actuated MDI were studied; therefore, results cannot be
extrapolated to others devices. However, Basheti and co-
workers showed similar results for patients treated with dry
powder inhalers.27,28
Inhaler technique, asthma control, pharmacy training 1821Assessment of control and adherence was performed via
a postal questionnaire, but the response rate was adequate
(63%), and there was no demographic or asthma-related
difference identified between patients who did and did not
respond to the questionnaire.
In addition, the self-reported adherence measure used is
not specific to asthma controller therapy.18
Future research needs
Several questions remain for future evaluation. Will the
positive short-term impact of inhaler training on asthma
control and adherence be confirmed in a long-term follow
up? Is one training session enough? A loss of initial skill has
been shown as early as one month after training for pMDI.
Repeated training is probably necessary and each contact
with health care professionals should be used to reinforce
initial education. Will participating pharmacists be able to
continue to evaluate and train all patients in every day
practice? Basheti et al.29 report that pharmacists who are
involved in continued patient training appear to be able to
better maintain their inhaler technique demonstration
skills. As a practical matter, it might be necessary to define
which patients are most likely to benefit from inhaler
technique training. High use of short-acting bronchodilator
has been suggested as a marker of poor asthma control that
is easy for pharmacists to assess.30 We believe that
a beneficial approach would be to formulate a frame-
workdincluding training, participation in a network, and
possibly remunerationdwith a defined role for pharmacists
in asthma training, similar to what has been suggested in
other areas such as diabetes, fighting tobacco addiction,
and contraception.
In conclusion, this assessment of inhaler technique in
the pharmacy indicates that three quarters of patients do
not have optimal technique and that prior inhaler training,
particularly with regard to individualised assessment and
guidance remains insufficient. Poor inhaler technique is
significantly associated with poor asthma control, even
after statistical adjustment for age, smoking, inhaler
device type, and self-reported adherence. Inhaler tech-
nique training as provided by pharmacists appears to be
feasible within everyday practice and improves inhaler
technique. The accompanying increases in asthma control
and self-reported adherence at one month should be
confirmed in longer studies. For asthma, as for other
conditions, the scope and practical application of patient
training by pharmacists remains to be defined.
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